These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19139982)

  • 21. Hypercholesterolemia in long-term survivors of liver transplantation: a comparison between cyclosporine and FK 506.
    Charco R; Cantarell C; Vargas V; Capdevila L; Esteban R; Lázaro JL; Margarit C
    Transplant Proc; 1998 Jun; 30(4):1489. PubMed ID: 9636605
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacovigilance of calcineurin inhibitor in peidatric kidney and liver transplantation].
    Riva N; Cáceres Guido P; Rousseau M; Dip M; Monteverde M; Imventarza O; Mato G; Schaiquevich P
    Farm Hosp; 2013; 37(6):441-9. PubMed ID: 24256007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age, model for end-stage liver disease score, and organ functioning predict posttransplant tacrolimus neurotoxicity.
    DiMartini A; Fontes P; Dew MA; Lotrich FE; de Vera M
    Liver Transpl; 2008 Jun; 14(6):815-22. PubMed ID: 18508372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycophenolate mofetil monotherapy in liver transplantation.
    Stewart SF; Hudson M; Talbot D; Manas D; Day CP
    Lancet; 2001 Feb; 357(9256):609-10. PubMed ID: 11558493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors.
    Carenco C; Faure S; Herrero A; Assenat E; Duny Y; Danan G; Bismuth M; Chanques G; Ursic-Bedoya J; Jaber S; Larrey D; Navarro F; Pageaux GP
    Liver Int; 2015 Jun; 35(6):1748-55. PubMed ID: 25488375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
    Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
    Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporine Versus Tacrolimus: Which Calcineurin Inhibitor Has Influence on Cytomegalovirus Infection in Cardiac Transplantation?
    Bond MMK; Bond MMK; Sehn A; Dias VH; Said TL; Dos Santos CC; Finger MA; Santos AMG; Neto JMR
    Transplant Proc; 2018 Apr; 50(3):809-814. PubMed ID: 29661443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe neurotoxicity in tacrolimus-treated living kidney transplantation in two cases.
    Veroux P; Veroux M; Puliatti C; Valvo M; Macarone M; Cappello D
    Urol Int; 2003; 71(4):433-4. PubMed ID: 14646448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotoxicity of calcineurin inhibitors: impact and clinical management.
    Bechstein WO
    Transpl Int; 2000; 13(5):313-26. PubMed ID: 11052266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporine-associated encephalopathy: a case report and literature review.
    Chang SH; Lim CS; Low TS; Chong HT; Tan SY
    Transplant Proc; 2001; 33(7-8):3700-1. PubMed ID: 11750577
    [No Abstract]   [Full Text] [Related]  

  • 31. Optimization of the use of Calcineurin inhibitors in liver transplantation.
    de Mare-Bredemeijer EL; Metselaar HJ
    Best Pract Res Clin Gastroenterol; 2012 Feb; 26(1):85-95. PubMed ID: 22482528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversible acute encephalopathy with mutism, induced by calcineurin inhibitors after renal transplantation.
    Toledo Perdomo K; Navarro Cabello MD; Pérez Sáez MJ; Ramos Pérez MJ; Agüera Morales ML; Aljama García P
    J Nephrol; 2012; 25(5):839-42. PubMed ID: 22252846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sirolimus and mycophenolate mofetil after liver transplantation.
    Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Tscheliessnigg KH
    Transpl Int; 2003 Jul; 16(7):504-9. PubMed ID: 12687325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mechanisms of nephrotoxic action of immunodepressants, calcineurine inhibitors].
    Nikitin AV
    Antibiot Khimioter; 2014; 59(1-2):44-7. PubMed ID: 25051716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Posterior reversible encephalopathy syndrome in the Intensive Care Unit after liver transplant: a comparison of our experience with the existing literature.
    Lunardi N; Saraceni E; Boccagni P; Segato M; Bortolato A; Manara R; Rossi S; Ori C
    Minerva Anestesiol; 2012 Jul; 78(7):847-50. PubMed ID: 21701444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse effects of immunosuppression after liver transplantation.
    Noble J; Terrec F; Malvezzi P; Rostaing L
    Best Pract Res Clin Gastroenterol; 2021; 54-55():101762. PubMed ID: 34874845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum Magnesium and Related Factors in Long-Term Renal Transplant Recipients: An Observational Study.
    Rodrigues N; Santana A; Guerra J; Neves M; Nascimento C; Gonçalves J; da Costa AG
    Transplant Proc; 2017 May; 49(4):799-802. PubMed ID: 28457398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcineurin inhibitors in pediatric renal transplant recipients.
    Filler G
    Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gangliocytoma Presenting With Tacrolimus Neurotoxicity in a Renal Transplant Recipient: Case Report.
    Alagoz S; Gulcicek S; Oruc M; Trabulus S; Seyahi N
    Transplant Proc; 2016 Nov; 48(9):3142-3144. PubMed ID: 27932167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longterm calcineurin inhibitor therapy and brain function in patients after liver transplantation.
    Pflugrad H; Schrader AK; Tryc AB; Ding X; Lanfermann H; Jäckel E; Schrem H; Beneke J; Barg-Hock H; Klempnauer J; Weissenborn K
    Liver Transpl; 2018 Jan; 24(1):56-66. PubMed ID: 29156491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.